The IJTLD
The IJTLD is the leading peer-reviewed journal dedicated to lung health worldwide.
We welcome submissions on basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
Public Health Action
Public Health Action aims to disseminate the latest operational research on health systems, public health and disease control.
We have recently expanded the scope of PHA to provide coverage of relevant areas of the UN's Sustainable Development Goals (SDGs).
IJTLD Open
Launched in January 2024, IJTLD Open is The Union's new Open Access journal for the latest research on TB and lung diseases including asthma, COVID-19 and COPD.
We welcome submissions on the development of diagnostics and treatments for the prevention, management and control of respiratory diseases.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
The second United Nations high-level meeting on the fight to end TB: action is needed to turn the tide by 2030
An Editorial in the September issue of PHA highlights the need to accelerate progress towards TB elimination.
Tackling TB in Europe: treatment gaps and deteriorating treatment availability is undermining progress
An Editorial in a forthcoming issue of the IJTLD highlights the need for access to medications for drugs for TB in Europe. The preprint is free to read.
Community perspective on child-friendly medications for drug-resistant TB: importance, priorities and advocacy
An Editorial in a forthcoming issue of the IJTLD highlights the need for child-friendly medications for drug-resistant TB. The preprint is free to read.